NASDAQ$OBIO
Orchestra Biomed Holdings In · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
OBIO Q2 2024 — $1.24B revenue, 30.00 EPS
All statements other than statements of historical facts contained in this report, including statements regarding our future results of operations and financial position, business strategy, product ca. Orchestra Biomed Holdings In reported Q2 2024 results. Diluted EPS came in at $30.00. Net income of $29.4M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $1.24B.
- Diluted EPS: $30.00.
- Net income: $29.4M.
Headline financials
Revenue & EPS history
Orchestra Biomed · Revenue · Quarterly
$778K
Revenue by segment
Orchestra Biomed · $2.64M total across 2 segments · Q4 2024
- Partnership revenue$2.01M-4.8%76.0%
- Product revenue$633K-3.2%24.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2024
+4.3%
Avg return
Earnings day
+2.2%
Avg return
5 days after
+5.7%
Avg return
30 days after
63%
12 / 19 earnings
Positive
+30.5%
Q4 2022
Best reaction
-6.0%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -4.9% | +4.1% | |
| Q4 2025 | +4.7% | +4.9% | -2.0% | |
| Q3 2025 | +4.6% | +12.4% | +9.1% | |
| Q2 2025 | -2.6% | +1.8% | +4.0% | |
| Q1 2025 | +0.3% | -5.9% | +16.6% | |
| Q4 2024 | -6.0% | -4.4% | -11.1% | |
| Q3 2024 | -1.0% | -4.7% | -12.9% | |
| Q2 2024 | -3.7% | +3.7% | -8.1% | |
| Q1 2024 | +10.4% | +10.6% | +68.6% | |
| Q4 2023 | +0.2% | -5.9% | -16.5% | |
| Q3 2023 | +29.6% | +28.8% | +58.3% | |
| Q2 2023 | +5.3% | -0.5% | +9.2% | |
| Q1 2023 | +2.5% | +15.3% | -16.8% | |
| Q4 2022 | +30.5% | -12.1% | -1.6% | |
| Q3 2022 | +0.3% | -0.4% | +0.1% | |
| Q2 2022 | +0.0% | +0.1% | +0.2% | |
| Q4 2021 | +0.0% | +0.2% | +0.4% | |
| Q1 2022 | +0.0% | +0.2% | +0.4% | |
| Q1 2021 | +3.7% | +1.8% | +6.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro